Dr. Janet Rowley, a pioneer in cancer genetics research, has died at age 88. Rowley spent most of her career at the University of Chicago, where she also obtained her medical degree.
A new study shows that ALK and ROS1 gene rearrangements known to drive subsets of lung cancer are also present in some colorectal cancers.
For some cancer patients, the mental fogginess that develops with chemotherapy lingers long after treatment ends. Now, research in breast cancer patients may offer an explanation.
A controversial oil and natural gas drilling technique called hydraulic fracturing, or fracking, uses many chemicals that can disrupt the body’s hormones, according to new research.
A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer.
Exercise might help women beat breast cancer. Researchers found it can ease the achy joints and muscle pain that lead many patients to quit taking medicines that treat the disease and lower the risk of a recurrence.
Scientists have identified a unique class of breast cancer cells that lead the process of invasion into surrounding tissues, the first step in the deadly process of cancer metastasis, and have found a way to stop that invasion process in mice.
A statistical analysis using the natural and orthogonal interaction (NOIA) model may be a better way to analyze the genetic causes of cutaneous melanoma (CM), according to a new study.
A new finding by scientists has identified key steps that trigger the disintegration of cellular regulation that leads to cancer.
Tens of thousands of women each year might be able to skip at least some of the grueling treatments for breast cancer— which can include surgery, heavy chemo and radiation— without greatly harming their odds of survival, new research suggests.
A simple blood test will soon be able to catch the vast majority of a group of chronic blood cancers, a new study reveals. The scientists also identified a new gene, CALR, which is altered in 40 percent of blood disorders.
Scientists have devised the first method to measure the push and pull of cells as embryonic tissue develops. The cells’ tiny forces are measured in 3-D tissues and living embryos.
Researchers have uncovered a genetic deficiency in males that can trigger the development of one of the most common types of liver cancer and forms of diabetes.
Harmless lung cancer? A provocative study found that nearly 1 in 5 lung tumors detected on CT scans are probably so slow-growing that they would never cause problems.
A new microchip-based device may greatly simplify the monitoring of patients’ response to treatment for ovarian cancer— the most lethal form of gynecologic cancer— and certain other malignancies.
In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy cancer.
ImmunoChemistry Technologies (ICT) has changed ownership and is now majority women-owned. The company will continue to develop new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans.
Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with those who quit smoking after diagnosis, according to a new study.
In search of better cancer treatments, researchers have designed synthetic molecules that combine the advantages of two experimental RNA therapies.
The most active component of grape seed extract, B2G2, induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed, according to a new study.
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers report.
Epidemiologists have designed a better method to quantify a woman’s risk of developing breast cancer, according to researchers.
Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a new study.
New findings show that eating a high-fat diet beginning at puberty speeds up the development of breast cancer and may actually increase the risk of cancer similar to a type often found in younger adult women.